RE: 8 weeks and counting11 Apr 2024 17:14
CJ39
“ It’s just been a disastrous 18 months since the Stalicla deal was announced. I’d like to hear from posters like xxxInvestorxxx, K3VMC, Trickymatters, Mozax for their take on things. I know we’ve not always agreed but they were all very civil and reasonable.”
Sorry, I’ve only just spotted this post.
I really like the Chronos acquisition.
“ Acquisition of Chronos Therapeutics, which features a neuropsychiatry portfolio including two assets developed to late pre-clinical stage and which sits within a resurgent area for Big Pharma, for £899,481 up front, and up to £2.5m in milestone payments, all in Evgen shares.”
Quite apart from the late stage products brought in with Chronos, they now have their neuropsychiatry experience and contacts. Since Stalicla may have decided to play hardball with EVG, they have the backup of taking sfx01 back off them and developing it through TheraCryf.
Clearly, whoever saddled them with “TheraCryf” a) thought they were being frightfully clever and b) has never been gifted a copy of “Marketing for Dummies”. Thankfully, their success will not depend on anything other than sfx001 efficacy in one or more of the many research projects going on. They are all worthy projects, but I think the gliablastoma research will get some additional prominence, due to President Biden’s interest in that field.
I added on the acquisition news, but I anticipated the subsequent slide - no stocks seem capable of sustaining any rise in this market. I added again today, so managed to get my average to 2.18p. If they have any commercial success at all, the first 3x should be an easy reach, but long term it could be stunning. If and could. Just my opinion.
I’ll be adding, gently.